Anthropic PBC will meet a select group of institutional investors at its San Francisco headquarters on October 14 as it prepares for an initial public offering that could rank among the largest in history, according to reports.
Bloomberg reported the meeting would let prospective buyers question senior executives directly, citing people familiar with the matter. Invitations have gone out to a select group of institutional investors, and the timing would put the Claude developer on track for an expected November debut. Formal IPO marketing could begin as early as the week of November 9, positioning the company to start trading before Thanksgiving — though details remain subject to change, and an Anthropic spokesperson declined to comment.
Separately, CNBC reported Anthropic will disclose its third-quarter 2026 financials for the first time at the gathering. Investors estimate fair value in the 1.8 trillion to 2 trillion dollar ballpark, people familiar with the matter have said. While Claude lacks ChatGPT’s household recognition, its adoption among businesses and software developers — including banks, hedge funds and enterprise software providers such as Salesforce — promises the steady revenue growth professional investors want.
What a listing would mean for the AI funding landscape
For the boardrooms watching the race, Anthropic’s path to market is a test of whether enterprise AI revenue can support public-market discipline. The pitch rests on businesses paying to embed Claude in their workflows — steady, contractable revenue professional investors favor. OpenAI, by contrast, has postponed its own IPO plans and is instead seeking at least 30 billion dollars from private investors at a roughly 1.4 trillion dollar valuation, Bloomberg has reported.
The compressed timetable carries risk: moving from first meetings to a November debut leaves little room for error in a volatile market. Sentiment helps — Goldman Sachs turned bullish on global equities this week on earnings optimism, and Wall Street braces for big-bank earnings as bond yields cloud the outlook. A strong earnings season gives Anthropic the receptive tape bankers dream of; a weak one could push the listing into 2027.
The enterprise-revenue test
Ultimately the listing will be priced on one question: can a research lab sustain the growth a two-trillion-dollar valuation demands under quarterly reporting? Private markets funded the buildout without that scrutiny; public markets will not. Wednesday’s meeting is management’s first sales pitch to the people who buy IPOs for a living — and their questions will be sharper than any benchmark.
